Literature DB >> 23785015

Comparison of near-infrared spectroscopy and optical coherence tomography for detection of lipid.

Taishi Yonetsu1, William Suh, Farhad Abtahian, Koji Kato, Rocco Vergallo, Soo-Joong Kim, Haibo Jia, Iris McNulty, Hang Lee, Ik-Kyung Jang.   

Abstract

OBJECTIVES: To compare intracoronary near-infrared spectroscopy (NIRS) and optical coherence tomography (OCT) for the detection of lipid, to identify NIRS signals to differentiate superficial lipid, and to characterize the plaque with yellow block (YB) chemograms on NIRS.
BACKGROUND: Intracoronary NIRS has been developed to detect lipid core plaque (LCP).
METHODS: We investigated a total of 17 patients who underwent both OCT and NIRS. NIRS analysis included plaque lipid core burden index (LCBI), LCP length, and the presence of YB on the block chemogram. OCT analysis included maximum lipid arc (LA), the length of lipid (LL), lipid index, and the thinnest fibrous cap thickness (FCT).
RESULTS: Twenty-five plaques with >40% plaque burden were analyzed. LCP, showing LCBI > 0, was observed in 20 plaques (80%) and YB was detected in seven plaques (28%). Plaque LCBI showed modest correlations with maximum LA and lipid index by OCT (r(2) = 0.319, P = 0.003 and r(2) = 0. 404, P = 0.001, respectively). Lipid length showed a significant correlation between NIRS and OCT measurements (r(2) = 0.581, P < 0.001). There was no significant difference in NIRS parameters between superficial and deep lipid. Plaques with YB compared with those without YB showed a larger LA, longer LL, and thinner FCT (185 ± 29° vs. 105 ± 76°, P = 0.014; 8.5 ± 3.3 mm vs. 3.3 ± 2.7 mm, P = 0.001; 112 ± 42 vs. 166 ± 61 µm, P = 0.033).
CONCLUSIONS: NIRS and OCT parameters showed modest linear correlations in the measurement of lipid. The accurate depth of lipid in the vessel wall could not be identified by quantitative NIRS parameters. YB chemograms represented more vulnerable features on OCT.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  atherosclerosis; optical coherence tomography; plaque; spectroscopy

Mesh:

Substances:

Year:  2013        PMID: 23785015     DOI: 10.1002/ccd.25084

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  5 in total

1.  The utility of total lipid core burden index/maximal lipid core burden index ratio within the culprit plaque to predict filter-no reflow: insight from near-infrared spectroscopy with intravascular ultrasound.

Authors:  Takao Sato; Yoshifusa Aizawa; Naomasa Suzuki; Yuji Taya; Sho Yuasa; Shohei Kishi; Tomoyasu Koshikawa; Koichi Fuse; Satoshi Fujita; Yoshio Ikeda; Hitoshi Kitazawa; Minoru Takahashi; Masaaki Okabe
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

Review 2.  Research and clinical applications of optical coherence tomography in invasive cardiology: a review.

Authors:  Luigi Vignali; Emilia Solinas; Enzo Emanuele
Journal:  Curr Cardiol Rev       Date:  2014-11

3.  Optical coherence tomography attenuation imaging for lipid core detection: an ex-vivo validation study.

Authors:  Muthukaruppan Gnanadesigan; Ali S Hussain; Stephen White; Simon Scoltock; Andreas Baumbach; Antonius F W van der Steen; Evelyn Regar; Thomas W Johnson; Gijs van Soest
Journal:  Int J Cardiovasc Imaging       Date:  2016-09-12       Impact factor: 2.357

4.  Serial Coronary Imaging of Early Atherosclerosis Development in Fast-Food-Fed Diabetic and Nondiabetic Swine.

Authors:  Nienke S van Ditzhuijzen; Mieke van den Heuvel; Oana Sorop; Alexia Rossi; Timothy Veldhof; Nico Bruining; Stefan Roest; Jurgen M R Ligthart; Karen Th Witberg; Marcel L Dijkshoorn; Koen Nieman; Monique T Mulder; Felix Zijlstra; Dirk J Duncker; Heleen M M van Beusekom; Evelyn Regar
Journal:  JACC Basic Transl Sci       Date:  2016-10-31

Review 5.  Review on Laser Technology in Intravascular Imaging and Treatment.

Authors:  Jing Li; Ce Shang; Yao Rong; Jingxuan Sun; Yuan Cheng; Boqu He; Zihao Wang; Ming Li; Jianguo Ma; Bo Fu; Xunming Ji
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.